The size of the North America Prefilled Syringes Market will be valued at USD 1.68 billion in 2023. It is estimated to grow at a CAGR of 5.51%, reaching USD 2.20 billion by 2028 during the forecast period.
The growing aging population and rise in the number of people suffering from diabetes across North America majorly drive the growth of the North American prefilled syringes market. Geriatric individuals are particularly susceptible to diabetes due to metabolic changes. Nearly 11% of the population is affected by diabetes in the United States. Patients managing elevated glucose levels often require insulin administration, either by healthcare professionals, nurses, or self-administration. For insulin users, prefilled insulin syringes are recommended to minimize dosage errors. These syringes are conveniently stored in refrigeration, maintaining the integrity of the solution.
The growing prevalence of chronic disease and rapid adoption of injectable drugs further boost the growth rate of the North American prefilled syringes market. The growing usage of prefilled syringes in the healthcare sector aids regional market growth. For healthcare providers, prefilled syringes provide a more convenient method for drug delivery. It also helps reduce needle stick injuries among patients and healthcare providers. Compared to the other drug forms, injections work more effectively on diseases or issues in the body. People who are living alone and people who are living far from the hospital are using prefilled syringes for various disorders.
The ongoing advancements in manufacturing and increasing R&D activities around advanced prefilled syringes further fuel the growth rate of the North American market. Manufacturers are diversifying prefilled syringe types to minimize medication errors and enhance structural durability during transportation and usage. The presence of key market participants and increasing investments by them for the R&D of prefilled syringes contributes to the growth rate of the North American market.
The high costs associated with certain prefilled syringes majorly hamper the growth of the North American prefilled syringes market. Factors such as insufficient awareness, limited availability across disease categories, and existing drug delivery options further impede regional market growth.
This research report on the North American prefilled syringes market has been segmented and sub-segmented into the following categories:
By Distribution Channel:
North America accounted for the largest share of the global market in 2022. The lead of the North American region in the worldwide market is anticipated to continue throughout the forecast period owing to advancements in treatment methodologies, increasing healthcare spending and the proliferation of prefilled syringe manufacturing facilities. The region's pharmaceutical firms prioritize affordable prefilled syringe development. Prefilled syringes have gained substantial traction in therapeutic applications and vaccine administration. The U.S. prefilled syringes market is expected to capture the leading share of the North American market during the forecast period. Factors such as accessible prefilled syringes in offline pharmacies with medical prescriptions and the facilitation of biologics delivery drive the U.S. market growth primarily. The growing number of awareness campaigns, advertising efforts by the market participants and the convenience of biologics delivery via prefilled syringes contributes to the U.S. market growth. Canada is estimated to account for a notable share of the North American market in the coming years owing to the improving clinical trial infrastructure, growing number of research centers and increased utilization within national vaccination initiatives.
KEY MARKET PLAYERS:
A few of the notable market participants operating in the North American Prefilled Syringes Market profiled in this report are Becton Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Ompi, Catalent, Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation & MedPro Inc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]